Stock listing

LSE:0GHZ Xspray Pharma AB Share Price

UK listing (LSE) of Xspray Pharma AB · home listing Stockholm:XSPRAY

Follow Xspray Pharma AB into a list and get an email when it puts out news.

Home listing price · OMXSTO:XSPRAY

11.64 SEK -0.16 (-1.4%)

Close on Nov 2, 2026 · This listing has no price on 6ix; the price shown is the home listing's, OMXSTO:XSPRAY

Past year -52.7% · daily closes, Nov 3, 2025 – Nov 2, 2026, adjusted for splits
Day range
11.40 – 12.44 SEKNov 2, 2026
Volume
54,240 sharesNov 2, 2026
Market cap
551.9M SEKAt the close on Nov 2, 2026 · price × 47.42M shares outstanding
52-week range
9.06 – 35.15 SEKLowest and highest trades, Nov 3, 2025 – Nov 2, 2026
Traded on an average day
1.28M SEKMedian day 68,220 shares · last 3 months, Aug 3, 2026 – Nov 2, 2026
Xspray Pharma AB logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
Stockholm:XSPRAY · Home11.64 SEK-0.16 (-1.4%)54,24011.8012.4411.4011.80Close on Nov 2, 2026
Frankfurt:6XP€0.898 EUR-0.003 (-0.3%)—€0.880€0.898€0.880€0.901Close on Oct 23, 2026

Daily closes

Last 3 months, Aug 3, 2026 – Nov 2, 2026 · OMXSTO:XSPRAY · SEK, adjusted for splits

DayCloseChange%OpenHighLowVolume
11.64-0.16-1.4%11.8012.4411.4054,240
11.80+1.10+10.3%10.8811.8010.7665,230
10.70+0.22+2.1%10.9010.9010.4043,691
10.48+0.10+1.0%10.3810.8410.2059,082
10.38+0.06+0.6%10.5610.5610.0818,210
10.32+0.08+0.8%10.2410.7810.187,150
10.24-0.06-0.6%10.7810.7810.1032,691
10.30-0.42-3.9%10.3211.2010.2052,515
10.72-0.24-2.2%10.8610.8610.6410,510
10.96+0.08+0.7%10.6210.9610.5214,376
10.88+0.14+1.3%10.7411.2010.469,735
10.74+0.12+1.1%10.7611.1610.7216,302
10.620.000.0%10.7411.5010.5068,211
10.62-0.20-1.8%10.8811.1210.6241,111
10.82-0.18-1.6%11.1611.3810.7034,457
11.00+0.30+2.8%10.6811.3410.6873,288
10.70+0.24+2.3%10.6010.8010.3041,933
10.46-0.42-3.9%10.7810.8410.3852,978
10.88-0.30-2.7%11.2411.2410.8221,339
11.18+0.40+3.7%10.9011.2010.5669,132
10.78-1.78-14.2%12.3812.3810.54204,582
12.56+2.04+19.4%10.6013.2610.60421,655
10.52-0.22-2.0%11.0011.0010.2496,100
10.74+0.79+7.9%10.1210.8010.12104,240
9.95+0.31+3.2%9.6510.209.4868,228
9.64+0.27+2.9%9.589.719.3053,875
9.37+0.16+1.7%9.739.739.3438,450
9.21-0.55-5.6%9.859.859.16115,804
9.76+0.56+6.1%9.2710.469.17161,926
9.20-0.05-0.5%9.209.469.0696,906
9.25-0.09-1.0%9.489.489.1862,234
9.34-0.35-3.6%9.809.839.2481,342
9.69+0.39+4.2%9.359.839.3560,985
9.30+0.02+0.2%9.309.459.2171,531
9.28-0.07-0.7%9.329.499.1468,842
9.35-0.32-3.3%9.639.719.3071,034
9.67+0.12+1.3%9.559.739.5525,412
9.55-0.31-3.1%9.9910.009.5586,633
9.86-0.16-1.6%10.0210.129.8143,685
10.020.000.0%10.1010.149.9614,728
10.02-0.06-0.6%10.0810.129.9339,288
10.08+0.02+0.2%10.0610.129.9025,258
10.06-0.04-0.4%10.0810.129.8639,721
10.10+0.17+1.7%10.0010.149.6998,299
9.93-0.11-1.1%10.1410.209.9175,396
10.04-0.02-0.2%10.2810.369.99137,349
10.06-0.18-1.8%10.4010.4010.00125,563
10.24-0.20-1.9%10.5810.6210.2477,724
10.44-0.30-2.8%10.7410.7410.3078,894
10.74+0.50+4.9%10.3010.7410.2097,686
10.24-0.22-2.1%10.5010.8010.24195,618
10.46+0.06+0.6%10.7410.7410.20139,781
10.40-0.20-1.9%10.8211.1610.26482,574
10.60-3.16-23.0%12.3812.4210.322,113,928
13.76+0.36+2.7%13.5214.2013.5256,788
13.40-0.30-2.2%13.7414.1613.30117,201
13.70-0.02-0.1%14.0014.4013.7081,530
13.72+0.02+0.1%13.7213.9813.4856,162
13.70-0.10-0.7%13.8014.2813.4056,364
13.80-0.54-3.8%14.4014.6613.54132,818
14.34-0.68-4.5%15.2015.2013.98133,638
15.02+0.30+2.0%15.0415.4014.76103,473
14.72-0.72-4.7%15.4415.5014.7287,646
15.44-1.16-7.0%16.0016.8014.94220,783
16.60+0.42+2.6%16.3416.7615.6041,076
16.18-0.70-4.1%16.9017.2415.8060,071
Ticker
LSE:0GHZ
Asset type
Stock
Exchange
LSE
Currency
SEK

What changed lately

Latest news

Xspray’s rights issue oversubscribed – over-allotment issue fully utilized

Apr 23, 2026

Closed 27.90 (-2.1%) on Apr 23, 2026

Xspray publishes disclosure document regarding rights issue

Mar 31, 2026

Closed 29.70 (+6.4%) on Mar 31, 2026

Xspray receives additional subscription undertakings; rights issue now covered to 110% and over-allotment issue increased

Mar 26, 2026

Closed 25.82 (-3.5%) on Mar 26, 2026

Xspray Pharma publishes its Annual Report 2025

Mar 26, 2026

Closed 25.82 (-3.5%) on Mar 26, 2026

Xspray resolves on a rights issue of approximately SEK 83 million with an over-allotment issue

Mar 24, 2026

Closed 26.74 (+9.3%) on Mar 25, 2026

Xspray Pharma: FDA accepts resubmitted application for market approval of Dasynoc® – PDUFA date August 25, 2026

Mar 11, 2026

Closed 25.72 (+8.2%) on Mar 11, 2026

Xspray Pharma re-submits its FDA application for Dasynoc

Feb 26, 2026

Closed 25.48 (-3.0%) on Feb 27, 2026

Xspray Pharma appoints Blake Leitch as CEO – Per Andersson continues as Chief Scientific Officer (CSO)

Feb 26, 2026

Closed 26.26 (+6.7%) on Feb 26, 2026

Xspray Pharma: FDA accepts New Drug Application for XS003 (nilotinib) for the treatment of CML - PDUFA date set for June 18, 2026

Oct 21, 2025

Xspray Pharma Submits XS003 to the FDA – The Company’s Second Product Candidate from the HyNap Platform

Aug 19, 2025

All Xspray Pharma AB news

Xspray Pharma AB on 6ix

News releases
8 in the last 12 months · 12 in all · newest Apr 23, 2026 · oldest 2025

Where Xspray Pharma AB is listed

ListingExchangeCountryCurrency
Stockholm:XSPRAY · Home listingStockholmSwedenSEK
LSE:0GHZ · This pageLSEUnited KingdomSEK
Frankfurt:6XPFrankfurtGermanyEUR
Lang & Schwarz:A2H48JLang & SchwarzGermanyEUR
LS Exchange:A2H48JLS ExchangeGermanyEUR
Aquis:XSPRASAquisUnited KingdomSEK
gettex:6XPgettexGermanyEUR
Aquis:XSPRASAquisUnited KingdomSEK
Stuttgart:6XPStuttgartGermanyEUR
Dusseldorf:6XPDusseldorfGermanyEUR
Munich:6XPMunichGermanyEUR

Log in to ask 6ix AI your own questions about Xspray Pharma AB.